Materias dentro de su búsqueda.
Mostrando 1,041 - 1,060 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 3.41s Limitar resultados
  1. 1041
    “…This study was conducted to make the network of miRNAs-mRNAs interactions in pancreatic cancer as the fourth leading cause of cancer death. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Network of microRNAs-mRNAs Interactions in Pancreatic Cancer
  2. 1042
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Aberrant MicroRNAs in Pancreatic Cancer: Researches and Clinical Implications
  3. 1043
    “…Clinical presentation of AIP overlaps that of pancreatic cancer (PC). Sometimes serum IgG4 and CA 19-9 levels are unable to differentiate AIP from PC. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Imaging of Focal Autoimmune Pancreatitis and Differentiating It from Pancreatic Cancer
  4. 1044
    “…METHODS: The Australian Pancreatic Cancer Genome Initiative (APGI) is an Australian contribution to the International Cancer Genome Consortium (ICGC), that involves prospective sequencing of tumor and normal genomes of study participants with pancreatic cancer in Australia. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Returning individual research results for genome sequences of pancreatic cancer
  5. 1045
    por Zhou, Yufeng
    Publicado 2014
    “…Pancreatic cancer is under high mortality but has few effective treatment modalities. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    High-Intensity Focused Ultrasound Treatment for Advanced Pancreatic Cancer
  6. 1046
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer
  7. 1047
    “…METHODS: Here, we examined the effects of KLT on the PI3K/Akt/mTOR pathway in pancreatic cancer xenografts in mice, and assessed its therapeutic potential. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antitumor effect of Kanglaite® injection in human pancreatic cancer xenografts
  8. 1048
    “…PPAR-γ ligands are known to inhibit numerous cancer cell processes, including pancreatic cancer cell proliferation through terminal differentiation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pioglitazone inhibits the proliferation and metastasis of human pancreatic cancer cells
  9. 1049
    “…However, the actions of insulin at the various stages of pancreatic cancer progression remain poorly defined. METHODS: Here, we examined the effects of a range of insulin doses on signalling, proliferation and survival in three human cell models meant to represent three stages in pancreatic cancer progression: primary pancreatic duct cells, the HPDE immortalized pancreatic ductal cell line, and the PANC1 metastatic pancreatic cancer cell line. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effects of insulin on human pancreatic cancer progression modeled in vitro
  10. 1050
    por Edderkaoui, Mouad, Eibl, Guido
    Publicado 2014
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Risk factors for pancreatic cancer: underlying mechanisms and potential targets
  11. 1051
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    To deny or not to deny surgical resection for pancreatic cancer to elderly patients?
  12. 1052
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identifying molecular subtypes related to clinicopathologic factors in pancreatic cancer
  13. 1053
    por Adamusiak, Tomasz, Shimoyama, Mary
    Publicado 2014
    “…BACKGROUND: Pancreatic cancer is one of the most common causes of cancer-related deaths in the United States, it is difficult to detect early and typically has a very poor prognosis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    EHR-based phenome wide association study in pancreatic cancer
  14. 1054
    “…BACKGROUND: We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an established primary tumor in the pancreas and if administration of metformin has an impact on tumor growth. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of diabetes type II and chronic inflammation on pancreatic cancer
  15. 1055
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Noncoding RNAs as potential biomarkers to predict the outcome in pancreatic cancer
  16. 1056
    por Leach, Steven D.
    Publicado 2015
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Interleukin interrupted: A new strategy for the treatment of pancreatic cancer
  17. 1057
    por Arem, Hannah, Yu, Kai, Xiong, Xiaoqin, Moy, Kristin, Freedman, Neal D., Mayne, Susan T., Albanes, Demetrius, Arslan, Alan A., Austin, Melissa, Bamlet, William R., Beane-Freeman, Laura, Bracci, Paige, Canzian, Federico, Cotterchio, Michelle, Duell, Eric J., Gallinger, Steve, Giles, Graham G., Goggins, Michael, Goodman, Phyllis J., Hartge, Patricia, Hassan, Manal, Helzlsouer, Kathy, Henderson, Brian, Holly, Elizabeth A., Hoover, Robert, Jacobs, Eric J., Kamineni, Aruna, Klein, Alison, Klein, Eric, Kolonel, Laurence N., Li, Donghui, Malats, Núria, Männistö, Satu, McCullough, Marjorie L., Olson, Sara H., Orlow, Irene, Peters, Ulrike, Petersen, Gloria M., Porta, Miquel, Severi, Gianluca, Shu, Xiao-Ou, Visvanathan, Kala, White, Emily, Yu, Herbert, Zeleniuch-Jacquotte, Anne, Zheng, Wei, Tobias, Geoffrey S., Maeder, Dennis, Brotzman, Michelle, Risch, Harvey, Sampson, Joshua N., Stolzenberg-Solomon, Rachael Z.
    Publicado 2015
    “…Our study included 3,583 pancreatic cancer cases and 7,053 controls from the genome-wide association studies of pancreatic cancer PanScans-I-III. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk
  18. 1058
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic cancer with portal vein invasion diagnosed by endoscopic ultrasound
  19. 1059
    “…Enhanced efforts to target subsets of patients with pancreatic cancer in order to optimize therapy benefit are warranted.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular landscape of pancreatic cancer: implications for current clinical trials
  20. 1060
    “…FOLFIRINOX (FFX) was introduced to clinical practice in 2010 following publication of the PRODIGE 4/ACCORD 11 study, which compared this novel regimen to gemcitabine in metastatic pancreatic cancer. Median overall survival, progression-free survival, and objective responses were all superior with FFX and there was improved time to definitive deterioration in quality of life. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Pancreatic cancer and FOLFIRINOX: a new era and new questions
Herramientas de búsqueda: RSS